Biohaven, after setbacks, sees shares jump with Oberland Capital funding agreement worth up to $600M
The company's shares jumped nearly 10% as of Monday afternoon, a welcome reprieve after the company's withdrawn bid for a European marketing authorization sparked concern among investors.
The company's shares jumped nearly 10% as of Monday afternoon, a welcome reprieve after the company's withdrawn bid for a European marketing authorization sparked concern among investors.
